Lymphotoxin-α Gene 252G Allelic Variant Is a Risk Factor for Large-Vessel-Associated Ischemic Stroke
A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding...
Saved in:
Published in | Journal of molecular neuroscience Vol. 27; no. 2; pp. 205 - 212 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke. |
---|---|
AbstractList | A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke.A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke. A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke. A direct role of lymphotoxin- alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the Intron 1 252A arrow right G (252G) transition, which naturally coexists with an exon 3 804C arrow right A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p < 0.025). Specific subclasslflcation of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p < 0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role In the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke. |
Author | Bene, Judit Somogyvári, Ferenc Komlósi, Katalin Bodor, Anita Szabó, Mihály Kondacs, András Szolnoki, Zoltán Talián, Gábor Melegh, Béla Havasi, Viktória Fodor, Lajos |
Author_xml | – sequence: 1 givenname: Zoltán surname: Szolnoki fullname: Szolnoki, Zoltán – sequence: 2 givenname: Viktória surname: Havasi fullname: Havasi, Viktória – sequence: 3 givenname: Gábor surname: Talián fullname: Talián, Gábor – sequence: 4 givenname: Judit surname: Bene fullname: Bene, Judit – sequence: 5 givenname: Katalin surname: Komlósi fullname: Komlósi, Katalin – sequence: 6 givenname: Ferenc surname: Somogyvári fullname: Somogyvári, Ferenc – sequence: 7 givenname: András surname: Kondacs fullname: Kondacs, András – sequence: 8 givenname: Mihály surname: Szabó fullname: Szabó, Mihály – sequence: 9 givenname: Lajos surname: Fodor fullname: Fodor, Lajos – sequence: 10 givenname: Anita surname: Bodor fullname: Bodor, Anita – sequence: 11 givenname: Béla surname: Melegh fullname: Melegh, Béla |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16186631$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9OGzEQhy2UqgTojTPyqSeW2t61184tQiSAUiqVlqvl9U6KYXcdbEcij8WL9Jkw4o9QhdTDaObwfaPR_HbQaPADILRPyREtJf92_v1iwuoJmzDCt9CYSMULKZQYvZu30U6MN4QwWlH5GW1TQaUQJR0jWGz61bVP_t4Nxd8HPIcBMONsjqddB52z-MoEZ4aEzyI2-KeLt3hmbPIBL3MtTPgDxRXECF0xjdFbZxK0GbbX0Gf7MgV_C3vo09J0Eb689F30e3by6_i0WPyYnx1PF4VlJU8FI7IBKOtatbxpW5MPbkjZ1MCWvC0lq4VgRlAgltSCCaPaSvGKibqivCpJU-6ir897V8HfrSEm3btooevMAH4dtZBZU4T-F6RKSc7VE3jwAq6bHlq9Cq43YaNfP5gB9gzY4GMMsNTWJZOcH1IwrtOU6KeYdI5Js1oznWPK0uE_0tvej_BHY4aRmw |
CitedBy_id | crossref_primary_10_1136_ard_2007_082594 crossref_primary_10_1016_j_exger_2008_04_006 crossref_primary_10_1542_peds_2007_3758 crossref_primary_10_1016_j_humgen_2022_201126 crossref_primary_10_1161_STROKEAHA_108_524587 crossref_primary_10_1556_CEMED_4_2010_2_2 crossref_primary_10_1186_1471_2164_7_281 crossref_primary_10_1016_j_ccell_2008_01_001 crossref_primary_10_4199_C00052ED1V01Y201204GMM001 crossref_primary_10_1161_STROKEAHA_107_510800 crossref_primary_10_1016_j_clineuro_2008_09_027 crossref_primary_10_1253_circj_72_1065 crossref_primary_10_1556_OH_2011_29113 crossref_primary_10_3109_00207454_2015_1134527 crossref_primary_10_1002_jgm_3229 crossref_primary_10_1007_s11883_006_0072_2 crossref_primary_10_1007_s11011_014_9584_6 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK 8FD FR3 H94 P64 RC3 7X8 |
DOI | 10.1385/JMN:27:2:205 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 0895-8696 |
EndPage | 212 |
ExternalDocumentID | 16186631 10_1385_JMN_27_2_205 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -Y2 .86 .GJ .VR 06C 06D 0R~ 0VX 0VY 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 4.4 406 408 40D 40E 44B 53G 5GY 5RE 5VS 67N 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHPBZ AHSBF AHWEU AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU CITATION COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 H13 HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M1P M2M M4Y MA- MVM N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR ZMTXR ZOVNA ~A9 ~EX -4W -56 -5G -BR -EM -~C 3V. ADINQ CGR CUY CVF ECM EIF GQ6 NPM Z7U Z82 Z83 Z87 Z8O Z8V Z91 7T5 7TK 8FD ABRTQ FR3 H94 P64 PJZUB PPXIY PUEGO RC3 7X8 |
ID | FETCH-LOGICAL-c235t-208bee3779d5bdda002b03b7e2f5d3827662a61e0c07626a9d4954267415430b3 |
ISSN | 0895-8696 |
IngestDate | Fri Jul 11 05:09:17 EDT 2025 Sun Aug 24 03:46:26 EDT 2025 Wed Feb 19 01:43:30 EST 2025 Tue Jul 01 03:06:00 EDT 2025 Thu Apr 24 22:55:23 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c235t-208bee3779d5bdda002b03b7e2f5d3827662a61e0c07626a9d4954267415430b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16186631 |
PQID | 19985591 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_68626901 proquest_miscellaneous_19985591 pubmed_primary_16186631 crossref_citationtrail_10_1385_JMN_27_2_205 crossref_primary_10_1385_JMN_27_2_205 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-00-00 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – year: 2005 text: 2005-00-00 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of molecular neuroscience |
PublicationTitleAlternate | J Mol Neurosci |
PublicationYear | 2005 |
References | 1750045 - Stroke. 1991 Nov;22(11):1379-83 12818249 - Thromb Res. 2003 Mar 15;109(5-6):265-9 10539839 - Am Heart J. 1999 Nov;138(5 Pt 2):S419-20 12829866 - Stroke. 2003 Aug;34(8):2050-9 10960044 - Brain. 2000 Sep;123 ( Pt 9):1784-812 9566356 - Neurology. 1998 Apr;50(4):841 and 11 pages following 8640995 - Circulation. 1996 Feb 15;93(4):672-82 9133511 - Circulation. 1997 Apr 15;95(8):2027-31 9180243 - Atherosclerosis. 1997 May;131(1):43-8 534423 - Ann Neurol. 1979 Sep;6(3):245-52 1670638 - J Exp Med. 1991 Jan 1;173(1):209-19 7886710 - Stroke. 1995 Mar;26(3):380-5 8821773 - Inflamm Res. 1996 Jan;45(1):14-9 7774281 - Curr Top Microbiol Immunol. 1995;198:175-218 9416885 - Circulation. 1997 Dec 16;96(12 ):4219-25 14638877 - J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1615-20 12663932 - J Mol Neurosci. 2003 Feb;20(1):31-8 12426569 - Nat Genet. 2002 Dec;32(4):650-4 3344216 - Nucleic Acids Res. 1988 Feb 11;16(3):1215 12382154 - J Neurol. 2002 Oct;249(10):1391-7 11809756 - J Biol Chem. 2002 Apr 5;277(14):12364-8 9183343 - Stroke. 1997 Jun;28(6):1158-64 |
References_xml | – reference: 9183343 - Stroke. 1997 Jun;28(6):1158-64 – reference: 12382154 - J Neurol. 2002 Oct;249(10):1391-7 – reference: 7886710 - Stroke. 1995 Mar;26(3):380-5 – reference: 9180243 - Atherosclerosis. 1997 May;131(1):43-8 – reference: 8821773 - Inflamm Res. 1996 Jan;45(1):14-9 – reference: 7774281 - Curr Top Microbiol Immunol. 1995;198:175-218 – reference: 11809756 - J Biol Chem. 2002 Apr 5;277(14):12364-8 – reference: 1670638 - J Exp Med. 1991 Jan 1;173(1):209-19 – reference: 12818249 - Thromb Res. 2003 Mar 15;109(5-6):265-9 – reference: 534423 - Ann Neurol. 1979 Sep;6(3):245-52 – reference: 9566356 - Neurology. 1998 Apr;50(4):841 and 11 pages following – reference: 10539839 - Am Heart J. 1999 Nov;138(5 Pt 2):S419-20 – reference: 10960044 - Brain. 2000 Sep;123 ( Pt 9):1784-812 – reference: 12426569 - Nat Genet. 2002 Dec;32(4):650-4 – reference: 12829866 - Stroke. 2003 Aug;34(8):2050-9 – reference: 8640995 - Circulation. 1996 Feb 15;93(4):672-82 – reference: 3344216 - Nucleic Acids Res. 1988 Feb 11;16(3):1215 – reference: 12663932 - J Mol Neurosci. 2003 Feb;20(1):31-8 – reference: 1750045 - Stroke. 1991 Nov;22(11):1379-83 – reference: 9133511 - Circulation. 1997 Apr 15;95(8):2027-31 – reference: 14638877 - J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1615-20 – reference: 9416885 - Circulation. 1997 Dec 16;96(12 ):4219-25 |
SSID | ssj0021418 |
Score | 1.8308024 |
Snippet | A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the... A direct role of lymphotoxin- alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 205 |
SubjectTerms | Aged Alleles Blood Vessels - pathology Brain Ischemia - genetics Brain Ischemia - physiopathology Female Genetic Predisposition to Disease Genotype Humans Lymphotoxin-alpha - genetics Lymphotoxin-alpha - metabolism Male Middle Aged Regression Analysis Risk Factors Stroke - genetics Stroke - physiopathology |
Title | Lymphotoxin-α Gene 252G Allelic Variant Is a Risk Factor for Large-Vessel-Associated Ischemic Stroke |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16186631 https://www.proquest.com/docview/19985591 https://www.proquest.com/docview/68626901 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9pAEF4Rcumlaps-6CPdQ9uL5RbvYq_hBhU0IOJWwUSoF2ttLxIKsatgqia_vjPrB0YK6uOAQZbtRTOfxzPjmW8IeRcrubTjuGOGittmR4nIRBZyk7uh4NKylzLG1MC555zNO5OFvWg0ZrWqpW0Wfozu7u0r-R-twj7QK3bJ_oNmq4vCDvgN-oUtaBi2f6Xj6S3oIs3SX6vENHTXrKaRNpjNvhj99Vohg_UlRMMgPmO8MaRxgZXkIz1jRxcYTrEQ3LxEAvG1WaoKfNAxBL26bH6W3aRX--VCOxf2upyta9RoMSukzO7SdZLmY7G_7yzdT7lZ7VXX-jrVohP0VXJA5YnWyV5Swq5bra5tuk4-prY0sXn7fwElVreXxamqsJ7sXqvOXSTAmJx7IH4mcIOf8tQ6hbb3NRjNp9PAHy78I3LMIHZgTXLcHw0GXhWHWx2d9q3-adEPAat8gjV6TPRYj-E8w7qnciD80G6I_4g8LIRP-zkYHpOGSp6Qk34is_T6ln6guqJXvyo5Ias6PqjGB0V8UMQHLfBBC3zQ8YZKivigOT4o4IMewAct8UFzfDwl89HQ_3xmFqM1zIhxO4O7yA2VQrLJ2A7jWIJUwjYPhWJw53KXCcdh0rFUO2rD09KR3RgCaXDm0P_s8HbIn5FmkibqBaHR0kVCJSE4EhNJ1bUiZDmM2xHsgudJixilGIOo4J3H8SfrQL9Mde0AhB4wEbAAhN4i76ujf-R8KweOe1tqJACDiG-5ZKLS7SbAplEIk63DR2BTFM5ha5HnuSp3K-H0CIdbL_949VfkgSbx1cm416SZ3WzVG3BPs_CUHImFOC1AB9-Dofft4jdGM5HA |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lymphotoxin-+alpha+Gene+252G+Allelic+Variant+Is+a+Risk+Factor+for+Large-Vessel-Associated+Ischemic+Stroke&rft.jtitle=Journal+of+molecular+neuroscience&rft.au=Szolnoki%2C+Z&rft.au=Havasi%2C+V&rft.au=Talian%2C+G&rft.au=Bene%2C+J&rft.date=2005&rft.issn=0895-8696&rft.volume=27&rft.issue=2&rft.spage=205&rft.epage=212&rft_id=info:doi/10.1385%2FJMN%3A27%3A2%3A205&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-8696&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-8696&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-8696&client=summon |